The Translational Research Working Group Developmental Pathway for anticancer agents (drugs or biologics)

Richard L. Schilsky, Gary Gordon, Tona M. Gilmer, Sara A. Courtneidge, Lynn M. Matrisian, Oren Grad, William G. Nelson

Research output: Contribution to journalReview article


The Translational Research Working Group (TRWG) was created as a national initiative to evaluate the current status of the National Cancer Institute's investment in translational research and envision its future. The TRWG conceptualized translational research as a set of six developmental processes or pathways focused on various clinical goals. One of those pathways describes the development of agents-both small molecules and biologics-for the treatment and prevention of cancer. The Agents Developmental Pathway was conceived not as a comprehensive description of the corresponding real-world processes, but rather as a tool designed to facilitate movement of an agent through the translational process to the point where it can begin definitive clinical testing. This article presents the Agents Developmental Pathway and discusses key challenges associated with the processes described.

Original languageEnglish (US)
Pages (from-to)5685-5691
Number of pages7
JournalClinical Cancer Research
Issue number18
StatePublished - Sep 15 2008


ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this